Researchers at Fox Chase Cancer Center have received a $497,000 multi-year grant from NCI to develop a way to evaluate novel drug therapies in patients with pancreatic cancer.
To access this subscriber-only content please log in or subscribe.
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe